The Career of Dr. Mark McKenna

Dr. Mark McKenna is a medical doctor and entrepreneur. He has spent a number of years practicing as surgeon as well as running a number of business ventures. While he was a surgeon, Mark built a reputation of providing excellent care and advocating for the well being of his patients. While Mark experienced a lot of success as a surgeon, he would also look to get into entrepreneurship as well. Dr. McKenna started up a real estate development firm as well as a company that provided mortgage lending services. These two companies helped make a difference in improving the New Orleans community. In terms of educational background, Mark attended Tulane University where he completed medical school. Once he was finished with his medical education and training, he would practice medicine for a few years.

When Hurricane Katrina hit New Orleans in 2005, Mark’s business interests were lost. However, Mark looked to make a difference in his community by rebuilding the city of New Orleans. He completed a number of redevelopment projects which entailed putting together low to moderate income housing units. This helped many people get much needed shelter after the hurricane. In the year 2007, Mark would relocated himself and his family to Atlanta, Georgia. Once he relocated, he started up a company named OVME which would specialize in medical aesthetics. He would also start up a practice known as ShapeMed which would provide medical services in wellness and medical aesthetics for patients.

Mark has attained a lot of success in business during Mark’s career. One of the things that has led to his success is to read on a regular basis. He says that the book Think and Grow Rich was instrumental in giving him the visionary mindset to reach his goals. Along with reading on a regular basis, Mark also says that it is beneficial to surround yourself with people that are smarter than you. With this approach, you will have the ability to get recommendations on how to reach a number of your business objectives more easily. Whenever he is not working, Mark spends time with his wife, daughter and pet dog along with training in the marital art JiuJitsu.

To Know More Click Here

Dr. Shiva Gopal Vasishta Advancing Research on Disease

Dr. Shiva Gopal Vasishta is a medical doctor who is solidly dedicated to the field of medicine. He is a prolific writer and contributor to various medical journals on subjects from EMG and EEG testing, myopathy, ALS disease, Diabetic conditions and nutrition in developing countries. His writing is often showcased in the pages of the internet magazine, crunchbase.

 

Dr. Shiva Gopal Vasishta was first educated in India where he graduated from the Government Medical College at Nagpur in 1979. He furthered his education at the Boston City Hospital. The good doctor trained under the guidance of several international authorities that included Dr. Theodore Munsat and John Kelly at Tufts University Medical Center.

Dr. Shiva Gopal Vasishta bases his neurological and psychiatric practice in Voorhees, New Jersey. Where he has been implementing a new breakthrough treatment for the treatment of multiple sclerosis (MS). According to a National Institute of Health (NIH) study that found stem cells can be effectively used in the treatment of MS. Called high-dose immunosuppressive treatment and referred to by the acronym HDIT/HCT. The treatment results are positive and 69% of the patients using this one-time method are reporting cessation of symptoms and other side effects. While further study is required, it is hoped that the HDIT/HCT stem cell treatment may replace the drugs being used in the treatment of MS. Education and research including the involvement of doctors like Visishta from across the world are discovering new drugs and treatments. Together their efforts offer encouragement to those suffering from MS and other diseases.

The international research and dedication by Dr. Shiva Gopal Vasishta and other researchers are bringing hope to the multitude of people suffering from debilitating diseases.